Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 27, 16:00
Avadel Pharmaceuticals Cash from Operations (Quarterly) : 23.27M for Sept. 30, 2025
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 23.27M |
| June 30, 2025 | 12.87M |
| March 31, 2025 | -8.232M |
| December 31, 2024 | 9.115M |
| September 30, 2024 | -7.654M |
| June 30, 2024 | -17.99M |
| March 31, 2024 | -29.70M |
| December 31, 2023 | -26.62M |
| September 30, 2023 | -38.45M |
| June 30, 2023 | -36.86M |
| March 31, 2023 | -30.23M |
| December 31, 2022 | -16.61M |
| September 30, 2022 | -4.710M |
| June 30, 2022 | -17.53M |
| March 31, 2022 | -34.04M |
| December 31, 2021 | -20.84M |
| September 30, 2021 | -20.34M |
| June 30, 2021 | -10.17M |
| March 31, 2021 | -23.41M |
| December 31, 2020 | -20.13M |
| September 30, 2020 | -11.42M |
| June 30, 2020 | -7.777M |
| March 31, 2020 | -11.64M |
| December 31, 2019 | -8.183M |
| September 30, 2019 | -7.191M |
| Date | Value |
|---|---|
| June 30, 2019 | -1.330M |
| March 31, 2019 | -21.21M |
| December 31, 2018 | -23.24M |
| September 30, 2018 | -19.40M |
| June 30, 2018 | -19.35M |
| March 31, 2018 | -18.01M |
| December 31, 2017 | -14.97M |
| September 30, 2017 | -1.738M |
| June 30, 2017 | 8.788M |
| March 31, 2017 | 25.31M |
| December 31, 2016 | 7.223M |
| September 30, 2016 | -4.920M |
| June 30, 2016 | -4.259M |
| March 31, 2016 | 20.37M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 25.28M |
| December 31, 2014 | -5.693M |
| September 30, 2014 | 3.50M |
| June 30, 2014 | -5.408M |
| March 31, 2014 | -2.398M |
| December 31, 2013 | -7.459M |
| September 30, 2013 | -0.3517M |
| June 30, 2013 | -5.791M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 415.70M |
| Perrigo Co. Plc | 82.60M |
| GH Research Plc | -14.94M |
| Cosmo NV | -- |
| Alkermes Plc | 145.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.788M |
| Cash from Financing (Quarterly) | 2.636M |